Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Cell, 2013-12, Vol.155 (6), p.1309-1322
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (39), p.16759-16765
2010
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Overcoming mutation-based resistance to antiandrogens with rational drug design
eLife, 2013-04, Vol.2, p.e00499
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
MAGI-2 scaffold protein is critical for kidney barrier function
Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14876-14881
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract 238: Androgen insensitivity syndrome germline loss-of-function mutations in the androgen receptor that acquire somatic gain-of-function in prostate cancer
Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.238-238
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade
Cell, 2013-12, Vol.155 (6), p.1309-1322
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
Journal of clinical oncology, 2023-08, Vol.41 (24), p.3988-3997
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
BRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)
Blood, 2021-11, Vol.138 (Supplement 1), p.2422-2422
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P1087: PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT
HemaSphere, 2023-08, Vol.7 (S3), p.e45636b5-n/a
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
Blood, 2022-11, Vol.140 (Supplement 1), p.9368-9372
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre-Treated Mantle Cell Lymphoma: Updated Results and Subgroup Analysis from the Phase 1/2 BRUIN Study With >3 Years Follow-Up from Start of Enrollment
Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S459-S459
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
POSTER: MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre-Treated Mantle Cell Lymphoma: Updated Results and Subgroup Analysis from the Phase 1/2 BRUIN Study With >3 Years Follow-Up from Start of Enrollment
Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S213-S213
2023
Volltextzugriff (PDF)
1 – 12 von 12
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen